Future Virology

Papers
(The median citation count of Future Virology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections85
The role of artificial intelligence in tackling COVID-1967
A comprehensive review about SARS-CoV-259
The role of miRNAs in COVID-19 disease58
A brief review on DNA vaccines in the era of COVID-1950
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach44
The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification44
Relationship between IL-6 and COVID-19: to be considered during treatment43
Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection39
Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor38
The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-1937
Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection32
Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-CoV-2 inhibitors31
Toll-like receptor 4 in COVID-19: friend or foe?29
Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time27
Fast evolution of SARS-CoV-2 driven by deamination systems in hosts21
Potential anti-COVID-19 activity of Egyptian propolis using computational modeling21
Xerostomia (dry mouth) in patients with COVID-19: a case series21
COVID-19 in homeless populations: unique challenges and opportunities19
Nanobodies: a new approach for the diagnosis and treatment of viral infectious diseases18
Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission17
Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis17
Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-215
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-1915
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA15
Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future14
Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis13
Genetic and pathogenic characterization of SARS-CoV-2: a review13
Pandemic response management framework based on efficiency of COVID-19 control and treatment13
Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy12
In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome12
Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: anin silicostudy12
Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran11
High-value laboratory testing for hospitalized COVID-19 patients: a review11
The COVID-19 pandemic: an increased risk of rheumatoid arthritis11
Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers10
Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome10
Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity9
Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery9
An overview of sex hormones in relation to SARS-CoV-2 infection9
Prediction and analysis of key protein structures of 2019-nCoV9
An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach9
COVID-19 and coronaviral hepatitis: evidence of collateral damage8
Natural killer cells in COVID-19: from infection, to vaccination and therapy8
Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic8
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes8
In-hospital clinical complications of COVID-19: a brief overview8
What is the intermediate host species of SARS-CoV-2?8
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: anin silicoperspective8
Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 28
Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh7
V483A: an emerging mutation hotspot of SARS-CoV-27
Brain tissue-resident immune memory cells are required for long-term protection against CNS infection with rabies virus7
A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols7
SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses7
HPV and its high-risk genotypes in Middle Eastern countries: a meta-analysis7
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise7
Association of anemia and COVID-19 in hospitalized patients7
Massive third-wave COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation7
Structural analysis of Spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations7
Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia6
Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent6
Nothing in SARS-CoV-2 makes sense except in the light of RNA modification?6
Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19?6
SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges6
Airborne transmission of SARS-CoV-2 disease (COVID-19)6
Research progress in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-196
Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset5
Association between blood groups and COVID-19 outcome in Iranian patients5
In silico study of potential anti-SARS cell entry phytoligands from Phlomis aurea: a promising avenue for prophylaxis5
Can anti-parasitic drugs help control COVID-19?5
Dengue outbreak 2018 in district Shangla KPK; clinical features and laboratory markers of dengue virus infection5
Reinfection and reactivation of SARS-CoV-25
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation5
Computational guided approach for drug repurposing against SARS-CoV-25
Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India5
Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report5
Thoughts on detecting tissue distribution of potential COVID-19 receptors5
Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition5
Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis5
Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity5
A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases5
Evidence-based policies in public health to address COVID-19 vaccine hesitancy4
The role of hepatitis B surface antibodies in HBV infection, disease and clearance4
Association between human herpesvirus-6 and primary brain tumors: a systematic review and meta-analysis4
Prevalence of HCV and/or HBV coinfection in Iranian HIV-infected patients4
The need for more robust research on the effectiveness of masks in preventing COVID-19 transmission4
SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system4
Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis4
Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study4
A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program4
Elevated levels of procoagulant microvesicles in patients with dengue fever4
The third booster vaccination dose against COVID-19: indications for circulating SARS-CoV-2 variants4
Synthetic antiviral peptides: a new way to develop targeted antiviral drugs4
Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-194
In silicodiscovery of non-psychoactive scaffolds inCannabishalting SARS-CoV-2 host entry and replication machinery4
The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic4
RT-LAMP is a potential future molecular diagnostic tool for influenza A virus4
‘The end’ – or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants4
LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?4
Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations4
Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic4
The potential of urine for human papillomavirus-related cervical cancer prevention3
Is the emergence of the zoonotic Langya virus amidst COVID-19 and monkeypox a cause for concern?3
Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report3
The novel antiviral properties of brassicasterol against human adenovirus3
A case series of pediatric COVID-19 with complicated symptoms in Iran3
Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review3
Evaluation of rapid antigen detection kits for the detection of SARS-CoV-2 B.1.617.2 virus3
Nanoparticle vaccines against respiratory syncytial virus3
Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA3
In silicostudies of fisetin and silymarin as novel chikungunya virus nonstructural proteins inhibitors3
Two sides of the same coin: the N-terminal and the receptor-binding domains of SARS-CoV-2 Spike3
Association between human Epstein–Barr virus and brain cancer: a systematic review and meta-analysis3
Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer3
The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on stability of the RBD–ACE2 complex3
Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-193
Vertical transmission and maternal passive immunity post-SARS-CoV-23
Virus spread in the liver: mechanisms, commonalities, and unanswered questions3
Viral sepsis: underrated and underdiagnosed entity in clinical arena3
Seroprevalence of the hepatitis E virus antibodies among blood donors in the Qassim region, Saudi Arabia3
Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report3
A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-23
Impact of influenza virus during pregnancy: from disease severity to vaccine efficacy3
The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period3
IgA nephropathy and spinal epidural abscess after COVID-19 infection: a case report3
In silico analysis of protein/peptide-based inhalers against SARS-CoV-22
An overview of chikungunya virus molecular biology, epidemiology, pathogenesis, treatment and prevention strategies2
Hepatitis E virus genotyping in Pakistan: a regional study to explore the implications for pregnant females2
Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus2
A nomogram predicting the severity of COVID-19 based on initial clinical and radiologic characteristics2
Mapping of SARS-CoV-2 spike protein evolution during the first and second waves of COVID-19 infections in India2
Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations2
Pediatric postviral autoimmune disorders of the CNS2
SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening2
Global epidemiology of HPV-associated recurrent respiratory papillomatosis and effect of vaccination2
Optimization of parameters for expression and purification of G glycoprotein ectodomain of respiratory syncytial virus2
A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?2
HIV and COVID-19 pandemic collision: turning challenges into opportunity2
Temporal variations in country-specific mutational profiles of SARS-CoV-2: effect on vaccine efficacy2
Do fever-relieving medicines have anti-COVID activity: an in silico insight2
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study2
Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-192
Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications?2
Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 20192
mRNA-based COVID-19 vaccines appear to not increase immune events in cancer patients receiving immune checkpoint inhibitors2
Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series2
A suspected case of COVID-19 turned into a confirmed case: a case report2
Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-192
CRISPR in HIV: dangers of CCR5 deletion2
Seasonal dynamics of varicella incidence in Bulgaria2
Cs-GRP78 recognition site on dengue virus envelope protein: in silico perspective2
New viruses on the rise: a One Health and ecosystem-based perspective on emerging viruses2
Molecular characterization and phylogenetic analyses of full-length viral genomes from Iranian patients with chronic hepatitis B virus2
Scope of computational biology and bioinformatics toward the discovery of potential therapeutic agents against viral diseases2
Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates2
Synthetic peptides as promising antiviral molecules2
A plain language summary of how well the single-dose Janssen vaccine works and how safe it is2
HIV infection and the risk of cancer: tumorigenicity of HIV-1 auxiliary proteins1
Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 20191
Hepatitis B virus reactivation: overview and management1
Rosmarinic acid inhibits Rift Valley fever virus: in vitro, computational and analytical studies1
Harnessing immunological targets for COVID-19 immunotherapy1
Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins1
Independent and incremental prognostic value of d-dimer in hospitalized COVID-19 patients1
Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach1
Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran1
Phylogenetic analysis and circulation pattern of human metapneumovirus strains in children with acute respiratory infection in Iran, 2014–20151
In silicodiscovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database1
HCV GT1b-patient with alanine aminotransferase elevation and sustained virologic response achieved by grazoprevir/elbasvir discontinuation1
Viral etiology of acute respiratory infections during 2014–2016 in Riyadh, Saudi Arabia1
Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients1
Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany1
Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age1
Emerging prevalence of fatty liver disease in HIV1
Evaluation of CCR5-Δ32 mutation and HIV-1 surveillance drug-resistance mutations in peripheral blood mononuclear cells of long-term non progressors of HIV-1-infected individuals1
Genetic characterization of G protein in respiratory syncytial virus ON-1 genotype in Tehran1
The international treaty for pandemic preparedness and response: same story, different times?1
Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings1
Apoptosis and autophagy as a turning point in viral–host interactions: the case of human norovirus and its surrogates1
Patient-reported outcomes for HIV: the future of long-acting injectables and antiretroviral therapy evaluations1
The role of Epstein–Barr virus-encoded latent membrane proteins in host immune escape1
Role of oxidative stress in the Epstein–Barr virus lifecycle and tumorigenicity1
Comparison of coxsackievirus A12 genome isolated from patients with different symptoms in Yunnan, Southwest China1
A retrospective analysis of neglected HIV-1 patients with middle-level viremia in Central China based on current policy1
Novel chimeric vectors harboring hepatitis B viral promoter and reporter gene demonstrated liver-specific significance1
FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B1
Efficiency rating of SG Diagnostics COVID-19 antigen rapid test kit1
Torque Teno virus and cancers: current knowledge1
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy1
p53 and rb promoter methylation in hepatitis C virus-related chronic hepatitis and hepatocellular carcinoma1
Low frequency of human cytomegalovirus in cancerous and precancerous cervical samples of Iranian women1
In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover1
Tissue is the issue: how altruistic people with HIV are changing the HIV tissue reservoir landscape1
Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old1
Parvovirus B19 affects thrombopoietin and IL-11 gene expression in human bone marrow mesenchymal stem cells1
Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY)1
COVID-19: studying the global pandemic – foreword1
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study1
Biological features of hepatitis B virus strains associated with fulminant hepatitis1
Welcome to the 17th volume of Future Virology1
The impact of EBV on the epigenetics of gastric carcinoma1
Rift Valley fever virus: a new avenue of research on the biological functions of amyloids?1
Inpatient and outpatient costs associated with respiratory syncytial virus in Japanese infants and older adults1
Evaluation of the immune memory response to routine HBV vaccine in Egyptian patients with Type 1 diabetes1
Hepatitis E virus in Saudi Arabia: more surveillance needed1
Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE21
The role of nanotechnology in overcoming barriers to phage therapy: an overview1
Genotoxicity: a neglected but potentially critical aspect of adenoviral COVID-19 vaccines1
In silico analysis of human T-lymphotropic virus type 1 complete genomes from patients with different clinical outcomes1
A meta-analysis on association between viral infections and Kawasaki disease in children1
Are ruminants and their products potential sources of human hepatitis E virus infection?1
0.030930042266846